Zusammenfassung
Anfang der 70er Jahre hoffte man noch, daß sich gerade das Mammakarzinom als Modell für Studien der Tumorimmunität eignen würde (Nathanson 1977). Von diesem Optimismus ist nicht viel übrig geblieben. Zwar waren die gelegentlich zu beobachtende lymphoide Infiltration und Aggregation von Plasmazellen im Tumorrandbereich schon lange bekannt, aber darin das histopathologische Äquivalent einer Immunreaktion vom verzögerten Typ zu sehen, hat sich nicht allgemein durchgesetzt. Immerhin geht die Infiltration mit Lymphozyten und Plasmazellen, wie sie beim medullären Karzinom beobachtet wird, mit einer relativ günstigen Prognose einher.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Bailey MJ, Ormerod MG, Imrie SF, Humphreys J, Roberts JDB, Gazet JC, Neville AM (1981) Comparative functional histopathology of human breast carcinoma xenografts. Br J Cancer 43:125–134.
Black MM, Zachrau RE, Shore B, Dion AS, Leis HP Jr. (1978) Cellular immunity to antologous breast cancer and R III-Murine mammary tumor virus preparations. Cancer Res 38:2068–2076.
Ceuppens J, Goodwin J (1981) Prostaglandins and the immune response to cancer (review). Anticancer Res 1:71–78.
Fritze D, Schulte-Uentrop C, Kaufmann M (1979) Leukocyte adherence inhibition (LAI) tests in patients clinically suspected of having breast cancer using a panel of breast carcinoma extracts. Eur J Cancer 15:1491–1496.
Fritze D, Kaufmann M, Fournier D v (1981) Frühdiagnostik des Mammakarzinoms mit Leukozyten-Adhärenz-Inhibitions(LAI)-Tests, in vitro. Dtsch. Ges. f. Senologie, Heidelberg 28.-29. 3. 1981.
Gillis S, Smith K (1977) Long term culture of tumor-specific cytotoxic T cells. Nature 268:154–156.
Goldrosen MH, Howell JH (1979) International workshop on leukocyte adherence inhibition. Cancer Res 39:555–662.
Golinger RC, Gregorio RM, Fisher ER (1977) Tumor cells in venous blood draining mammary carcinomas. Arch Surg 112:707–708.
Höffken K, Schmidt CG (1980) Immunkomplexe bei malignen Erkrankungen: Tumormarker oder Epiphänomen? Dtsch Med Wochenschr 105:1697–1699.
Howard DR, Taylor C (1979) A method for distinguishing benign from malignant breast lesions utilizing antibody present in normal human sera. Cancer 43:2279–2287.
Kamiyama M, Hashim GA, Kyriakidis G, Fitzpatrick HF (1980): A tumor-associated antigen isolated from human breast adenocarcinoma. Clin Immunol Immunopathol 16:151–165.
Krown SE, Pinsky CM, Wanebo HJ, Braun DW, Wong PP, Oettgen HF (1980) Immunologic reactivity and prognosis in breast cancer. Cancer 46:1746–1752.
Leung JP, Plow EF, Nakamura RM, Edgington TS (1978) A glykoprotein set specifically associated with the surface and cytosol of human breast carcinoma cells. J Immunol 121:1287–1296.
Nathanson L (1977) Immunology and immunotherapy of human breast cancer. Cancer Immunol Immunother 2:209–224.
Old LJ (1981) Cancer immunology: The search for specificity — G. H. A. Clowes memorial lecture. Cancer Res 4:361–375.
Pross HF, Baines MG (1977) Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. VI. A brief review. Cancer Immunol Immunother 3:75–85.
Sloane JP, Ormerod MG (1981) Distribution of epithelial membrane antigen in normal and neoplastic tissues and its value in diagnostic tumor pathology. Cancer 47:1786–1795.
Spiegelman S, Keydar I, Mesa-Tejada R, Ohno T, Ramanarayanan M, Nayak R, Bausch J, Fenoglio C (1980) Possible diagnostic implications of a mammary tumor virus related protein in human breast cancer. Cancer 46:879–892.
Springer GF, Murthy MS, Desai PR, Scanlou EF (1980) Breast cancer patient’s cell-mediated immune response to Thomsen-Friedenreich (T)antigen. Cancer 45:2949–2954.
Tsang PH, Tangnavarad K, Lesnick G, Perloff M, Holland JF, Bekesi JG (1980) Radioisotopic 51Cr-leukocyte adherence inhibition (LAI) assay. I. Demonstration of anti-tumor immunity in patients with breast carcinoma. J Immunol Methods 36:119–135.
Turnbull R, Turner TL, Fräser JD, Lloyd RS, Lang CJ, Wright R (1978) Autoantibodies in early breast cancer: a stage-related phenomenom? Br J Cancer 38:461–463.
Vose BM, Moore M (1979) Suppressor cell activity of lymphocytes infiltrating human lung and breast tumors. Int J Cancer 24:579–585.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag, Berlin Heidelberg
About this paper
Cite this paper
Fritze, D. (1984). Immunität beim Mammakarzinom. In: Kubli, F., von Fournier, F. (eds) Neue Konzepte der Diagnostik und Therapie des Mammakarzinoms. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68088-5_35
Download citation
DOI: https://doi.org/10.1007/978-3-642-68088-5_35
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-68089-2
Online ISBN: 978-3-642-68088-5
eBook Packages: Springer Book Archive